This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange declined 11.40 points to 537.52 Friday, ending the week down 35.69 points. Douglas Ford's halted capital pool shell, Zorro Capital Corp. (ZOR), plans to acquire Kent Imaging Inc., a Calgary medical imaging company, as its qualifying transaction.

Zorro will roll back 1:5, leaving it with 1,215,000 postconsolidated shares, and then issue 10.6 million postconsolidated shares at a deemed value of $1 a share to Kent's securityholders, after which Zorro will change its name to Kent Imaging Inc. Donald Chapman, the founder and chief executive officer of Kent, will take over as Zorro's CEO, join the board and receive approximately 2.3 million shares.

Kent, founded in 2006, has developed an FDA-cleared product it calls the Kent Camera, which takes pictures of a patient and reveals to a doctor whether his patient's tissue is receiving enough blood and oxygen. The camera uses near-infrared technology, which Kent says passes harmlessly through the skin and is then reflected off the blood supplying the tissue to determine tissue oxygen saturation, an important indicator of tissue health. The company claims its Kent Camera can help with wound care, surgery, optometry, vascular diseases and diabetes. For now, judging by the limited financials available concerning Kent's operations, the world does not appear to be beating a path to its door. The company had operating expenses of $851,443 in its fiscal year ended Nov. 30, 2014, and a net loss of $688,967. Detailed financials will arrive when Zorro submits a filing statement.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS